Sudair Pharmaceutical Company
Yasser Alobaida is the Chief Executive Officer and Founder of Sudair Pharmaceutical Company, where responsibilities encompass the establishment and daily operations since January 2014. In addition to this role, Yasser serves on various advisory boards, including the College of Pharmacy at King Saud University and NEOM. Yasser holds the position of Vice Chairman at the Council of Saudi Chambers and is a Board Member at the Saudi Food and Drug Authority (SFDA), National Unified Procurement Company (NUPCO), and has previously held significant roles at Security Forces Hospital in Riyadh. Additionally, Yasser contributed to the Ministry of Interior in Saudi Arabia as a member of the Constitutional Council of Medical Cities and has been involved with various health care accreditation bodies throughout a distinguished career.
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.